Mengzheng Guo

Mengzheng Guo

Auto-generated profile, based on publicly available information

Mengzheng Guo

Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LWLiwen Wang
Liwen Wang
ZYZhiwei Yue
Zhiwei Yue
MGMengzheng Guo
Mengzheng Guo
LFLianying Fang
Lianying Fang
LBLiang Bai
Liang Bai
Hui ZhaoHui Zhao
Hui Zhao
Hyperoside, an active compound found in plants of the generaHypericumandCrataegus, is reported to exhibit antioxidant, anticancer, and anti-inflammatory activities. Induction of hepatic stellate cell (HSC) apoptosis is recognized as a promising strategy for attenuation of hepatic fibrosis. In this study, we investigated whether hyperoside treatment can exert antifibrotic effects in human LX-2 hepatic stellate cells. We found that hyperoside induced apoptosis in LX-2 cells and decreased levels ofα-smooth muscle actin (α-SMA), type I collagen, and intracellular reactive oxygen species (ROS). Remarkably, hyperoside also inhibited the DNA-binding activity of the transcription factor NF-κB and altered expression levels of NF-κB-regulated genes related to apoptosis, including proapoptotic genesBcl-Xs,DR4,Fas, andFasLand anti-apoptotic genesA20,c-IAP1,Bcl-XL, andRIP1. Our results suggest that hyperoside may have potential as a therapeutic agent for the treatment of liver fibrosis.